Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

被引：0

作者：

David R. Coghill

Tobias Banaschewski

Peter Nagy

Isabel Hernández Otero

César Soutullo

Brian Yan

Beatriz Caballero

Alessandro Zuddas

机构：

[1] University of Melbourne,Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences

[2] University of Dundee,Central Institute of Mental Health

[3] Medical Faculty Mannheim,Child and Adolescent Neuropsychiatry Unit, Department of Biomedical Sciences

[4] University of Heidelberg,undefined

[5] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,undefined

[6] University Hospital Virgen de la Victoria,undefined

[7] University of Navarra Clinic,undefined

[8] Shire,undefined

[9] Shire,undefined

[10] University of Cagliari,undefined

来源：

CNS Drugs | 2017年 / 31卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：625 / 638

页数：13

共 50 条

[21] Efficacy and safety of lurasidone in adolescents with schizophrenia: analysis of a 2-year, open-label extension study
Goldman, R.
Tocco, M.
Pikalov, A.
Ling, D.
Loebel, A.
EUROPEAN PSYCHIATRY, 2019, 56 : S275 - S276
[22] Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD Final Report of a 4-Year Study
Adler, Lenard A.
Spencer, Thomas J.
Williams, David W.
Moore, Rodney J.
Michelson, David
JOURNAL OF ATTENTION DISORDERS, 2008, 12 (03) : 248 - 253
[23] Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia:: a 2-year, open-label extension study
Luetjohann, D.
von Bergmann, K.
Sirah, W.
Macdonell, G.
Johnson-Levonas, A. O.
Shah, A.
Lin, J.
Sapre, A.
Musliner, T.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (10) : 1499 - 1510
[24] Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy
Shinnar, Shlomo
Pellock, John M.
Conry, Joan A.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (01) : 3 - 9
[25] A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder
Childress, Ann C.
Lloyd, Eric
Johnson, Steven A., Jr.
Gunawardhana, Lhanoo
Arnold, Valerie
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (02) : 98 - 106
[26] Efficacy and safety of lurasidone in children and adolescents with bipolar depression: Results from a 2-year open-label extension study
DelBello, M. P.
Goldman, R.
Tocco, M.
Pikalov, A.
Deng, L.
Loebel, A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S236 - S236
[27] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
Haibel, H.
Brandt, H. C.
Baraliakos, X.
Rudwaleit, M.
Listing, J.
Braun, J.
Kupper, H.
Sieper, J.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
[28] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
Santos, Raul D.
Duell, P. Barton
East, Cara
Guyton, John R.
Moriarty, Patrick M.
Chin, Wai
Mittleman, Robert S.
EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
[29] Cisapride in the long-term treatment of chronic gastroparesis: A 2-year open-label study
Kendall, BJ
Kendall, ET
Soykan, I
McCallum, RW
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1997, 25 (04) : 182 - 189
[30] Tofacitinib in patients with moderate to severe chronic plaque psoriasis: 2-year efficacy and safety in an open-label long-term extension study
Paul, Carle
Langley, Richard G.
Valenzuela, Fernando
Cather, Jennifer
Gardner, Annie
Proulx, James
Tan, Huaming
Wolk, Robert
Kaur, Mandeep
Rottinghaus, Scott
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB278 - AB278

← 1 2 3 4 5 →